Abstract
In the current Chapter, we describe our results of our studying SARS-CoV-2 spread in Russia and comparison of its epidemiology with other viruses of acute respiratory panel in January-June 2020. 12,082 persons already proven positive for SARS-CoV-2 (Group 1) and 7,864 + 4,458 (Group 2) persons with respiratory suspicions were investigated. In Russia, in January-June 2020, the number of deaths of pneumonia of different non-COVID-19-related aetiology can be estimated as some 16,000 people (Rosstat data). Current number of deaths with COVID-19 diagnosed is twice less. It is considerable, but proper steps in surveillance, prevention, diagnosis and treatment may effectively curb it. In January-June 2019, there were 15,206 fatalities of pneumonia, and in 2012–2016 approximately 16,000–28,000 humans. Therefore, in Russia the current risk of contagiousness and fatality associated with SARS-CoV-2 is statistically comparable with the risk from other human coronaviruses and many other acute respiratory viral pathogens that already became seasonal, and less than that of pneumonia of different aetiology. It does not mean, however, that we may relax, as this emerging pathogen turned out to be less dangerous than we deemed several months ago. A search for new therapeutics against SARS-CoV-2 must continue along with development and improvement of new medical vaccines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Roussel Y, Giraud-Gatineau A, Jimeno MT et al (2020) SARS-CoV-2: fear versus data. Int J Antimicrob Agents:105947. https://doi.org/10.1016/j.ijantimicag.2020.105947
Lee PI, Hu YL, Chen PY et al (2020) Are children less susceptible to COVID-19? J Microbiol Immunol Infect 53(3):371–372. https://doi.org/10.1016/j.jmii.2020.02.011
Jean SS, Lee PI, Hsueh PR (2020) Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect 53(3):436–443. https://doi.org/10.1016/j.jmii.2020.03.034
Duan YN, Zhu YQ, Tang LL et al (2020) CT features of novel coronavirus pneumonia (COVID-19) in children. Eur Radiol 14:1–7. https://doi.org/10.1007/s00330-020-06860-3
Mehta NS, Mytton OT, Mullins EWS et al (2020) SARS-CoV-2 (COVID-19): What do we know about children? a systematic review. Clin Infect Dis:ciaa556. https://doi.org/10.1093/cid/ciaa556
Chen F, Fu D, Yang Q et al (2020) Low transmission risk of 9 asymptomatic carriers tested positive for both SARS-CoV-2 nucleic acid and serum IgG. J Infect S0163–4453(20):30416–30423. https://doi.org/10.1016/j.jinf.2020.06.034
Park SW, Cornforth DM, Dushoff J et al (2020) The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak. Epidemics 31: https://doi.org/10.1016/j.epidem.2020.100392
Gao M, Yang L, Chen X et al (2020) A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respir Med 169: https://doi.org/10.1016/j.rmed.2020.106026
Sassin W (2019) Deja Vue? Beacon J Stud Ideol Ment Dimens 2(2):020210216. https://doi.org/10.5281/zenodo.3733442, https://hdl.handle.net/20.500.12656/thebeacon.2.020210216
Sassin W (2019) De-creation of creation, or a new level of culture in the development of homo. Beacon J Stud Ideol Ment Dimens 2:020510203. https://doi.org/10.5281/zenodo.3732508, https://hdl.handle.net/20.500.12656/thebeacon.2.020510203
Ko WC, Rolain JM, Lee NY et al (2020) Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents 55(4): https://doi.org/10.1016/j.ijantimicag.2020.105933
Sharov KS (2020) Adaptation to SARS-CoV-2 under stress: role of distorted information. Eur J Clin Invest:e13294. https://doi.org/10.1111/eci.13294
Devaux CA, Rolain JM, Raoult D (2020) ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425–435. https://doi.org/10.1016/j.jmii.2020.04.015
Raoult D, Hsueh PR, Stefani S, Rolain JM (2020) COVID-19 therapeutic and prevention. Int J Antimicrob Agents 55(4): https://doi.org/10.1016/j.ijantimicag.2020.105937
Simera I, Moher D, Hoey J et al (2010) A catalogue of reporting guidelines for health research. Eur J Clin Invest 40(1):35–53. https://doi.org/10.1111/j.1365-2362.2009.02234.x
Fitchett EJA, Seale AC, Vergnano S et al (2016) Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis 16(10):e202–e213. https://doi.org/10.1016/s1473-3099(16)30082-2
Colson P, La Scola B, Esteves-Vieira V et al (2020) Letter to the editor: plenty of coronaviruses but no SARS-CoV-2. Euro Surveill 25(8):2000171. https://doi.org/10.2807/1560-7917.es.2020.25.8.2000171
Nicholson A, Shah CM, Ogawa VA (eds) (2019) Exploring lessons learned from a century of outbreaks: readiness for 2030. National Academies Press, Washington, DC
Touzard-Romo F, Tapé C, Lonks JR (2020) Co-infection with SARS-CoV-2 and human metapneumovirus. R I Med J 103(2):75–76. http://www.rimed.org/rimedicaljournal/2020/03/2020-03-75-touzard-romo.pdf
Kim D, Quinn J, Pinsky B et al (2020) Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 323(20):2085–2086. https://doi.org/10.1001/jama.2020.6266
Donskikh OA (2019) Horror zivilisationis, or the horror of subjectivity. Beacon J Stud Ideol Ment Dimens 2(2):020110205. https://doi.org/10.5281/zenodo.3733791, https://hdl.handle.net/20.500.12656/thebeacon.2.020110205
Stopcoronavirus (2020) Official website of the Russian official headquarters on control and monitoring of coronavirus situation. https://xn--80aesfpebagmfblc0a.xn--p1ai. Accessed 21 June 2020
Acknowledgements
We would like to thank Nikolay Belousov, Polina Chernova, Maria Dolgova, Leonid Gerasimov, Anna Gorenintseva, Elizaveta Ilyina, Pavel Ivanov, Tatiana Kartseva, Ekaterina Koshkina, Mikhail Marushkevich, Sofia Petrova, Alexandra Sheveleva, Alexander Sokolov, Anastasia Sonina, Alexei Volodin, Vadim Zhuravlyov (Russia) for their technical and informational support in working with samplings and data sets, for providing the clinical data vital for the analysis.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sharov, K.S. (2021). SARS-CoV-2 in Acute Respiratory Infection Situation in Russia in Spring–Summer 2020. In: Legach, F.a.E.I., Sharov, K.S. (eds) SARS-CoV-2 and Coronacrisis. Springer, Singapore. https://doi.org/10.1007/978-981-16-2605-0_4
Download citation
DOI: https://doi.org/10.1007/978-981-16-2605-0_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-2604-3
Online ISBN: 978-981-16-2605-0
eBook Packages: Social SciencesSocial Sciences (R0)